These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10437645)

  • 21. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis.
    Tsai WC; Li YH; Chao TH; Chen JH
    J Formos Med Assoc; 2002 Oct; 101(10):681-4. PubMed ID: 12517040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cameroonian professional soccer players and risk of atherosclerosis.
    Nansseu JR; Ama Moor VJ; Takam RDM; Zing-Awona B; Azabji-Kenfack M; Tankeu F; Tchoula CM; Moukette BM; Ngogang JY
    BMC Res Notes; 2017 Jun; 10(1):186. PubMed ID: 28577561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation.
    Fang JC; Kinlay S; Behrendt D; Hikita H; Witztum JL; Selwyn AP; Ganz P
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2044-8. PubMed ID: 12482832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between lipoprotein- and oxidation-related variables and atheroma lipid composition in subjects undergoing coronary artery bypass graft surgery.
    Craig WY; Rawstron MW; Rundell CA; Robinson E; Poulin SE; Neveux LM; Nishina PM; Keilson LM
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1512-7. PubMed ID: 10364083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL.
    Swets BP; Brouwer DA; Tervaert JW
    Clin Exp Immunol; 2001 Apr; 124(1):163-7. PubMed ID: 11359456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina.
    Ogawa H; Soejima H; Takazoe K; Miyamoto S; Kajiwara I; Shimomura H; Sakamoto T; Yoshimura M; Kugiyama K; Kimura M; Yasue H
    Angiology; 2001 Mar; 52(3):167-74. PubMed ID: 11269779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein.
    He L; Qin S; Dang L; Song G; Yao S; Yang N; Li Y
    Biochim Biophys Acta; 2014 Dec; 1841(12):1709-15. PubMed ID: 25240836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of autoantibodies against oxidized LDL (oLAB) and blood antioxidant status in professional soccer players.
    Kłapcińska B; Kempa K; Sobczak A; Sadowska-Krepa E; Jagsz S; Szołtysek I
    Int J Sports Med; 2005; 26(1):71-8. PubMed ID: 15643538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease].
    Maggi E; Perani G; Falaschi F; Frattoni A; Martignoni A; Finardi G; Stefano PL; Simeone F; Paolini G; DeVecchi E
    Presse Med; 1994 Jul 2-9; 23(25):1158-62. PubMed ID: 7971845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of metabolic control on oxidized low-density lipoprotein antibodies in children and adolescents with type 1 diabetes mellitus.
    Kara C; Cetinkaya S; Sezgin N; Kinik ST
    Pediatr Diabetes; 2008 Feb; 9(1):17-22. PubMed ID: 18211632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against oxidised low-density lipoprotein in hypopituitary patients with growth hormone deficiency.
    Ozbey N; Aydin A; Telci A; Cakatay U
    Endocr J; 2001 Oct; 48(5):579-84. PubMed ID: 11789563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis.
    Bui MN; Sack MN; Moutsatsos G; Lu DY; Katz P; McCown R; Breall JA; Rackley CE
    Am Heart J; 1996 Apr; 131(4):663-7. PubMed ID: 8721636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.